Quick Answer
CASTLE BIOSCIENCES INC reported Total Revenue of $344.23 million for the year ending 2025.
- CASTLE BIOSCIENCES INC showed an increase of +3.7% in Total Revenue from 2024 to 2025.
- This data is from CASTLE BIOSCIENCES INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2018: $3.66 million | Q2 2018: $3.98 million | Q3 2018: $3.71 million | Q4 2018: $11.44 million | Q1 2019: $8.72 million | Q2 2019: $10.74 million | Q3 2019: $14.77 million | Q4 2019: $17.64 million | Q1 2020: $17.42 million | Q2 2020: $12.72 million | Q3 2020: $15.22 million | Q4 2020: $17.30 million | Q1 2021: $22.81 million | Q2 2021: $22.76 million | Q3 2021: $23.48 million | Q1 2022: $26.85 million | Q2 2022: $34.84 million | Q3 2022: $37.01 million | Q1 2023: $42.04 million | Q2 2023: $50.14 million | Q3 2023: $61.49 million | Q1 2024: $72.97 million | Q2 2024: $87.00 million | Q3 2024: $85.78 million | Q1 2025: $87.99 million | Q2 2025: $86.19 million | Q3 2025: $83.04 million.
- Over the full 8 years of available data (2018 to 2025), CASTLE BIOSCIENCES INC's Total Revenue has grown by 1,410.7%.
- Historical annual values: Fiscal year 2025: $344.23 million | Fiscal year 2024: $332.07 million | Fiscal year 2023: $219.79 million | Fiscal year 2022: $137.04 million | Fiscal year 2021: $94.09 million | Fiscal year 2020: $62.65 million | Fiscal year 2019: $51.87 million | Fiscal year 2018: $22.79 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: